Recruiting NA Spinal Metastases

New treatment option for Spinal Metastases

Official title D20054;LITT for Spine Tumors

ClinicalTrials.gov ID: NCT06548061

What this study is testing

What it's testing
The objective of this clinical study is to evaluate the efficacy and safety of spinal laser interstitial therapy in the treatment of metastatic spinal tumors. The investigators hypothesize that rates of local tumor control are comparable between conventional open surgical techniques and spinal laser interstitial therapy.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Histology confirmed spinal tumor involving the T2-T12 spine segments.
  • Indication for spine stereotactic radiosurgery or palliative intervention.
  • Normal neurologic exam at the time of presentation (Frankel grade E).

You likely can't join if

  • Contraindication to MRI
  • ANY neurologic deficit
  • Tumor spanning more than 3 consecutive vertebral segments
  • Contraindication to general anesthesia
  • Pregnancy

The study team makes the final eligibility decision.

Where it's taking place

  • Lebanon, New Hampshire, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Lebanon, New Hampshire, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.